Individuals with attention‐deficit/hyperactivity disorder (ADHD) exhibit varied responses to pharmacological treatments (e.g. stimulants and non‐stimulants). Accurately and promptly detecting treatment‐related improvements, response failure, or deterioration poses significant challenges, as current monitoring primarily relies on subjective ratings. In this commentary, we critically evaluate the evidence supporting the use of QbTest for objectively monitoring ADHD treatment response in clinical practice. We also offer recommendations for future research, advocating for rigorous clinical trials and longitudinal studies to further explore the potential utilisation of QbTest and other tools for monitoring treatment responses in individuals with ADHD.

中文翻译：

---

评论：使用 QbTest 监测 ADHD 的药物治疗反应 – 我们到了吗？


患有注意力缺陷/多动障碍 （ADHD） 的个体对药物治疗 （例如 兴奋剂和非兴奋剂） 表现出不同的反应。准确及时地检测与治疗相关的改善、反应失败或恶化带来了重大挑战，因为目前的监测主要依赖于主观评级。在本评论中，我们批判性地评估了支持在临床实践中使用 QbTest 客观监测 ADHD 治疗反应的证据。我们还为未来的研究提供建议，倡导严格的临床试验和纵向研究，以进一步探索 QbTest 和其他工具的潜在用途，以监测 ADHD 患者的治疗反应。